|
S100P expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.505600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.290600E-01 |
| Normal-vs-Stage2 |
1.355360E-01 |
| Normal-vs-Stage3 |
5.935600E-01 |
| Normal-vs-Stage4 |
4.234200E-01 |
| Stage1-vs-Stage2 |
8.604200E-02 |
| Stage1-vs-Stage3 |
3.842400E-01 |
| Stage1-vs-Stage4 |
7.348800E-01 |
| Stage2-vs-Stage3 |
5.913900E-02 |
| Stage2-vs-Stage4 |
1.062000E-01 |
| Stage3-vs-Stage4 |
6.336800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.883000E-01 |
| Normal-vs-AfricanAmerican |
3.149400E-01 |
| Normal-vs-Asian |
2.674800E-01 |
| Caucasian-vs-AfricanAmerican |
5.614000E-01 |
| Caucasian-vs-Asian |
1.529600E-01 |
| AfricanAmerican-vs-Asian |
9.810200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.078000E-01 |
| Normal-vs-Female |
3.375800E-01 |
| Male-vs-Female |
7.490200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.568400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.825600E-01 |
| Normal-vs-Age(61-80Yrs) |
4.142200E-01 |
| Normal-vs-Age(81-100Yrs) |
2.559800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.327000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.188600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.960200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.148000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.378800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.366200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.565000E-01 |
| Classical-VS-Follicular |
1.982610E-01 |
| Classical-VS-Other |
4.199600E-02 |
| Classical-VS-Normal |
4.305400E-01 |
| Tall-VS-Follicular |
3.117800E-01 |
| Tall-VS-Other |
1.054000E-01 |
| Tall-VS-Normal |
4.336000E-01 |
| Follicular-VS-Other |
2.818400E-01 |
| Follicular-VS-Normal |
2.195200E-01 |
| Other-VS-Normal |
7.979600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.351200E-01 |
| Normal-vs-N1 |
1.815990E-01 |
| N0-vs-N1 |
2.392000E-01 |
|
|
